Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Director · Chairman, CEO and President | May 07, 2026 | May 11, 2026 |
| BOEING COBA · Entity 2862 | Director | July 01, 2026 | July 06, 2026 |
| NORFOLK SOUTHERN CORPNSC · Entity 2965 | Director | March 10, 2017 | March 14, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 505,160 |
Reported balance
After 2026-05-07 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-07 · Tax withholding · Disposed 2,079 · Balance 505,160 F1: These shares include 1,273 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| Common StockSEC Table I · non-derivative | IndirectBy GRAT | 60,060 |
Reported balance
Holding disclosure · report date 2026-05-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 60,060 |
| Common StockSEC Table I · non-derivative | IndirectBy Spousal GRAT | 60,060 |
Reported balance
Holding disclosure · report date 2026-05-07 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 60,060 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 29,940 |
Reported balance
Holding disclosure · report date 2026-05-07 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 29,940 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares include 1,273 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
BOEING CO
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 16,282.795 |
Reported balance
After 2026-07-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 406 · Balance 16,282.795 F1: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2: Phantom stock units awarded or acquired in lieu of director cash compensation. F3: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: Phantom stock units are convertible into common stock on a 1-for-1 basis.
F2: Phantom stock units awarded or acquired in lieu of director cash compensation.
F3: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.
NORFOLK SOUTHERN CORP
Report date March 10, 2017 · Filed March 14, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 11,717.4372 |
Reported balance
After 2017-03-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-03-10 · Grant · Acquired 59.3214 · Balance 11,717.4372 F1: Reports the number of restricted stock units credited to the reporting person's account in the Norfolk Southern Corporation Long-Term Incentive Plan in the form of dividend equivalent payments on restricted stock units held under the plan, calculated on the basis of the market value of the company's common stock on the dividend payment date. These units ultimately will be satisfied in common stock upon the reporting person's termination of service or death. |
| Common StockSEC Table I · non-derivative | Direct | 3,000 |
Reported balance
Holding disclosure · report date 2017-03-10 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 3,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Reports the number of restricted stock units credited to the reporting person's account in the Norfolk Southern Corporation Long-Term Incentive Plan in the form of dividend equivalent payments on restricted stock units held under the plan, calculated on the basis of the market value of the company's common stock on the dividend payment date. These units ultimately will be satisfied in common stock upon the reporting person's termination of service or death.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 03, 2022 Filed Oct 5, 2022 22:49 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 715.236 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010832 · doc4.xml · derivative · entry 1 Bradway Robert A · CIK 0001396482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,544.817 Underlying: Common Stock · 715.236 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| July 01, 2022 Filed Jul 7, 2022 00:17 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 640.355 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008682 · doc4.xml · derivative · entry 1 Bradway Robert A · CIK 0001396482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,829.581 Underlying: Common Stock · 640.355 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| May 05, 2022 Filed May 9, 2022 23:00 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,017 | $236.10 | $476,213.70 |
DisclosureSEC source: 0001127602-22-013868 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 619,841 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,369 RSUs which will vest on 5/3/2023; 8,164 RSUs which vest in installments of 4,021 on 5/5/2023 and 4,143 on 5/5/2024; 13,280 RSUs which vest in two installments of 4,382 on 4/30/2023 and 4/30/2024 and one installment of 4,516 on 4/30/2025; and 13,781 RSUs which will vest in installments of 4,547 on 5/2/2024, 4,548 on 5/2/2025, and 4,686 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 1,439 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 03, 2022 Filed May 4, 2022 23:44 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,692 | $230.92 | $621,636.64 |
DisclosureSEC source: 0001127602-22-013339 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 621,858 F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 5,369 RSUs which will vest in an installment of 5,369 on 5/3/2023; 12,184 RSUs which vest in installments of 4,020 on 5/05/2022, 4,021 on 5/5/2023 and 4,143 on 5/5/2024; 13,280 RSUs which vest in two installments of 4,382 on 4/30/2023 and 4/30/2024 and one installment of 4,516 on 4/30/2025; and 13,781 RSUs which will vest in installments of 4,547 on 5/2/2024, 4,548 on 5/2/2025, and 4,686 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 1,688 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 02, 2022 Filed May 4, 2022 23:44 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 112,508 | $0.00 Strike: $230.92 | $0.00 |
DisclosureSEC source: 0001127602-22-013339 · form4.xml · derivative · entry 3 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,508 Underlying: Common Stock · 112,508 shares Expires 2032-05-02 F4 · derivative.exercise_date: These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/2/2024, 5/2/2025 and 5/2/2026, respectively Read SEC document |
| May 02, 2022 Filed May 4, 2022 23:44 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 13,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-013339 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 624,550 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/2/2024, 5/2/2025 and 5/2/2026, respectively. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:37 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,547 | $249.87 | $636,418.89 |
DisclosureSEC source: 0001127602-22-012758 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 610,769 F1 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 10,580 RSUs which vest in installments of 5,211 on 5/3/2022 and 5,369 on 5/3/2023; 12,184 RSUs which vest in installments of 4,020 on 5/05/2022, 4,021 on 5/5/2023 and 4,143 on 5/5/2024; and 13,280 RSUs which vest in two installments of 4,382 on 4/30/2023 and 4/30/2024 and one installment of 4,516 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 2,174 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 22:32 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 465.396 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-005623 · doc4.xml · derivative · entry 1 Bradway Robert A · CIK 0001396482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,189.226 Underlying: Common Stock · 465.396 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 21:37 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 17,481 | $235.86 | $4,123,068.66 |
DisclosureSEC source: 0001127602-22-010185 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613,316 F1 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 4,790 RSUs which will vest on 4/27/2022; 10,580 RSUs which vest in installments of 5,211 on 5/3/2022 and 5,369 on 5/3/2023; 12,184 RSUs which vest in installments of 4,020 on 5/05/2022, 4,021 on 5/5/2023 and 4,143 on 5/5/2024; and 13,280 RSUs which vest in two installments of 4,382 on 4/30/2023 and 4/30/2024 and one installment of 4,516 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 2,773 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:23 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 34,964 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008130 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 630,141 F1 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 4,790 RSUs which will vest on 4/27/2022; 10,580 RSUs which vest in installments of 5,211 on 5/3/2022 and 5,369 on 5/3/2023; 12,184 RSUs which vest in installments of 4,020 on 5/05/2022, 4,021 on 5/5/2023 and 4,143 on 5/5/2024; and 13,280 RSUs which vest in two installments of 4,382 on 4/30/2023 and 4/30/2024 and one installment of 4,516 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 2,410 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 01:22 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 428.86 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000511 · doc4.xml · derivative · entry 1 Bradway Robert A · CIK 0001396482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,723.83 Underlying: Common Stock · 428.86 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 22:32 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 396.81 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-012951 · doc4.xml · derivative · entry 1 Bradway Robert A · CIK 0001396482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,294.97 Underlying: Common Stock · 396.81 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| July 01, 2021 Filed Jul 7, 2021 00:18 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 385.72 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-010338 · doc4.xml · derivative · entry 1 Bradway Robert A · CIK 0001396482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,898.16 Underlying: Common Stock · 385.72 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| May 03, 2021 Filed May 4, 2021 01:44 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,850 | $239.64 | $682,974.00 |
DisclosureSEC source: 0001127602-21-015045 · form4.xml · nonDerivative · entry 3 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 594,173 F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 4,790 RSUs which will vest on 4/27/2022; 10,580 RSUs which vest in installments of 5,211 on 5/3/2022 and 5,369 on 5/3/2023; 12,184 RSUs which vest in installments of 4,020 on 5/05/2022, 4,021 on 5/5/2023 and 4,143 on 5/5/2024; and 13,280 RSUs which vest in two installments of 4,382 on 4/30/2023 and 4/30/2024 and one installment of 4,516 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 1,406 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 01, 2021 Filed May 4, 2021 01:44 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,902 | $239.64 | $695,435.28 |
DisclosureSEC source: 0001127602-21-015045 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 597,023 Read SEC document |
| April 30, 2021 Filed May 4, 2021 01:44 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 115,307 | $0.00 Strike: $239.64 | $0.00 |
DisclosureSEC source: 0001127602-21-015045 · form4.xml · derivative · entry 4 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,307 Underlying: Common Stock · 115,307 shares Expires 2031-04-30 F4 · derivative.exercise_date: These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively. Read SEC document |
| April 30, 2021 Filed May 4, 2021 01:44 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 13,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-015045 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 599,925 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively. Read SEC document |
| April 27, 2021 Filed Apr 28, 2021 23:55 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,617 | $255.52 | $668,695.84 |
DisclosureSEC source: 0001127602-21-014594 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 586,645 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,019 RSUs which will vest on 5/1/2021; 4,790 RSUs which will vest on 4/27/2022; 15,791 RSUs which vest in two installments of 5,211 on 5/3/2021 and 5/3/2022 and one installment of 5,369 on 5/3/2023; and 12,184 RSUs which vest in installments of 4,020 on 5/05/2022, 4,021 on 5/5/2023 and 4,143 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 2,311 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:50 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 328.95 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-006531 · doc4.xml · derivative · entry 1 Bradway Robert A · CIK 0001396482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,512.44 Underlying: Common Stock · 328.95 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| March 19, 2021 Filed Mar 22, 2021 22:21 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 21,190 | $244.42 | $5,179,259.80 |
DisclosureSEC source: 0001127602-21-011708 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 589,262 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,019 RSUs which vest on 5/1/2021; 9,439 RSUs which vest in installments of 4,649 on 4/27/2021 and 4,790 on 4/27/2022; 15,791 RSUs which vest in two installments of 5,211 on 5/3/2021 and 5/3/2022 and one installment of 5,369 on 5/3/2023; and 12,184 RSUs which vest in installments of 4,020 on 5/05/2022, 4,021 on 5/5/2023 and 4,143 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 2,728 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 02, 2021 Filed Mar 5, 2021 01:20 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 38,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009476 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609,806 F1 · security: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,019 RSUs which vest on 5/1/2021; 9,439 RSUs which vest in installments of 4,649 on 4/27/2021 and 4,790 on 4/27/2022; 15,791 RSUs which vest in two installments of 5,211 on 5/3/2021 and 5/3/2022 and one installment of 5,369 on 5/3/2023; and 12,184 RSUs which vest in installments of 4,020 on 5/05/2022, 4,021 on 5/5/2023 and 4,143 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,019 RSUs which vest on 5/1/2021; 9,439 RSUs which vest in installments of 4,649 on 4/27/2021 and 4,790 on 4/27/2022; 15,791 RSUs which vest in two installments of 5,211 on 5/3/2021 and 5/3/2022 and one installment of 5,369 on 5/3/2023; and 12,184 RSUs which vest in installments of 4,020 on 5/05/2022, 4,021 on 5/5/2023 and 4,143 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 2,382 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| February 18, 2021 Filed Feb 23, 2021 00:27 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 73,500 | $0.00 Strike: $54.69 | $0.00 |
DisclosureSEC source: 0001127602-21-007182 · form4.xml · derivative · entry 3 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 73,500 shares Expires 2021-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2021 Filed Feb 23, 2021 00:27 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 47,527 | $235.61 | $11,197,836.47 |
DisclosureSEC source: 0001127602-21-007182 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 570,853 F1 · balance_after: Non-market exercise of a total of 73,500 stock options expiring April 25, 2021 wherein 47,527 shares, in the aggregate, issuable pursuant to the exercise of these options were withheld by the Company to cover the option exercise price and tax withholding, with the remaining shares delivered to the reporting person. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 5,019 RSUs which vest on 5/1/2021; 9,439 RSUs which vest in installments of 4,649 on 4/27/2021 and 4,790 on 4/27/2022; 15,791 RSUs which vest in two installments of 5,211 on 5/3/2021 and 5/3/2022 and one installment of 5,369 on 5/3/2023; and 12,184 RSUs which vest in installments of 4,020 on 5/05/2022, 4,021 on 5/5/2023 and 4,143 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 2,382 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| February 18, 2021 Filed Feb 23, 2021 00:27 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 73,500 | $54.69 | $4,019,715.00 |
DisclosureSEC source: 0001127602-21-007182 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 618,380 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:25 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 405.87 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000590 · doc4.xml · derivative · entry 1 Bradway Robert A · CIK 0001396482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,183.49 Underlying: Common Stock · 405.87 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 20:16 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 495.08 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012167 · doc4.xml · derivative · entry 1 Bradway Robert A · CIK 0001396482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,777.62 Underlying: Common Stock · 495.08 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:19 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 451.91 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-009592 · doc4.xml · derivative · entry 1 Bradway Robert A · CIK 0001396482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,282.54 Underlying: Common Stock · 451.91 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| May 05, 2020 Filed May 8, 2020 00:53 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 102,031 | $0.00 Strike: $236.36 | $0.00 |
DisclosureSEC source: 0001127602-20-015858 · form4.xml · derivative · entry 2 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,031 Underlying: Common Stock · 102,031 shares Expires 2030-05-05 F4 · derivative.exercise_date: These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/5/2022, 5/5/2023 and 5/5/2024, respectively. Read SEC document |
| May 05, 2020 Filed May 8, 2020 00:53 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 12,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015858 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 543,966 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/5/2022, 5/5/2023 and 5/5/2024, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 5,019 RSUs which vest on 5/1/2021; 9,439 RSUs which vest in installments of 4,649 on 4/27/2021 and 4,790 on 4/27/2022; 15,791 RSUs which vest in two installments of 5,211 on 5/3/2021 and 5/3/2022 and one installment of 5,369 on 5/3/2023; and 12,184 RSUs which vest in installments of 4,020 on 5/05/2022, 4,021 on 5/5/2023 and 4,143 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 1,468 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 03, 2020 Filed May 5, 2020 23:48 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,759 | $230.98 | $637,273.82 |
DisclosureSEC source: 0001127602-20-015542 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531,782 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,019 RSUs which vest on 5/1/2021; 9,439 RSUs which vest in installments of 4,649 on 4/27/2021 and 4,790 on 4/27/2022; and 15,791 RSUs which vest in two installments of 5,211 on 5/3/2021 and 5/3/2022 and one installment of 5,369 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 1,468 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 01, 2020 Filed May 5, 2020 23:48 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,737 | $239.22 | $654,745.14 |
DisclosureSEC source: 0001127602-20-015542 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534,541 Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 22:52 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,543 | $236.28 | $600,860.04 |
DisclosureSEC source: 0001127602-20-014694 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 537,278 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 4,784 RSUs which vest on 5/3/2020; 9,890 RSUs which vest in installments of 4,871 on 5/1/2020 and 5,019 on 5/1/2021; 9,439 RSUs which vest in installments of 4,649 on 4/27/2021 and 4,790 on 4/27/2022; and 15,791 RSUs which vest in two installments of 5,211 on 5/3/2021 and 5/3/2022 and one installment of 5,369 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 2,455 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 13, 2020 Filed Apr 13, 2020 23:54 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 84,000 | $0.00 Strike: $58.43 | $0.00 |
DisclosureSEC source: 0001127602-20-013652 · form4.xml · derivative · entry 6 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,000 shares Expires 2020-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 13, 2020 Filed Apr 13, 2020 23:54 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 43,000 | $0.00 Strike: $58.43 | $0.00 |
DisclosureSEC source: 0001127602-20-013652 · form4.xml · derivative · entry 5 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 43,000 shares Expires 2020-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 13, 2020 Filed Apr 13, 2020 23:54 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 55,695 | $218.21 | $12,153,205.95 |
DisclosureSEC source: 0001127602-20-013652 · form4.xml · nonDerivative · entry 4 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,821 F1 · balance_after: Non-market exercise of a total of 127,000 stock options expiring April 26, 2020 wherein 84,206 shares, in the aggregate, issuable pursuant to the exercise of these options were withheld by the Company to cover the option exercise price and tax withholding, with the remaining shares delivered to the reporting person. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 4,784 RSUs which vest on 5/3/2020; 9,890 RSUs which vest in installments of 4,871 on 5/1/2020 and 5,019 on 5/1/2021; 14,087 RSUs which vest in installments of 4,648 on 4/27/2020, 4,649 on 4/27/2021 and 4,790 on 4/27/2022; and 15,791 RSUs which vest in two installments of 5,211 on 5/3/2021 and 5/3/2022 and one installment of 5,369 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 2,730 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 13, 2020 Filed Apr 13, 2020 23:54 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 84,000 | $58.43 | $4,908,120.00 |
DisclosureSEC source: 0001127602-20-013652 · form4.xml · nonDerivative · entry 3 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 595,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 13, 2020 Filed Apr 13, 2020 23:54 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 28,511 | $218.21 | $6,221,385.31 |
DisclosureSEC source: 0001127602-20-013652 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 511,516 Read SEC document |
| April 13, 2020 Filed Apr 13, 2020 23:54 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 43,000 | $58.43 | $2,512,490.00 |
DisclosureSEC source: 0001127602-20-013652 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 22:19 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 610.47 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-006080 · doc4.xml · derivative · entry 1 Bradway Robert A · CIK 0001396482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,830.63 Underlying: Common Stock · 610.47 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 21:59 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 27,818 | $198.76 | $5,529,105.68 |
DisclosureSEC source: 0001127602-20-011866 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497,027 F1 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 4,784 RSUs which vest on 5/3/2020; 9,890 RSUs which vest in installments of 4,871 on 5/1/2020 and 5,019 on 5/1/2021; 14,087 RSUs which vest in installments of 4,648 on 4/27/2020, 4,649 on 4/27/2021 and 4,790 on 4/27/2022; and 15,791 RSUs which vest in two installments of 5,211 on 5/3/2021 and 5/3/2022 and one installment of 5,369 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 2,730 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:41 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 55,683 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009707 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 524,066 F1 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 4,784 RSUs which vest on 5/3/2020; 9,890 RSUs which vest in installments of 4,871 on 5/1/2020 and 5,019 on 5/1/2021; 14,087 RSUs which vest in installments of 4,648 on 4/27/2020, 4,649 on 4/27/2021 and 4,790 on 4/27/2022; and 15,791 RSUs which vest in two installments of 5,211 on 5/3/2021 and 5/3/2022 and one installment of 5,369 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 2,374 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 23:20 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 253.38 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000561 · doc4.xml · derivative · entry 1 Bradway Robert A · CIK 0001396482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,186.69 Underlying: Common Stock · 253.38 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 21:05 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 221.13 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-013177 · doc4.xml · derivative · entry 1 Bradway Robert A · CIK 0001396482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,910.4 Underlying: Common Stock · 221.13 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 20:30 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 233.11 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-010055 · doc4.xml · derivative · entry 1 Bradway Robert A · CIK 0001396482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,668.45 Underlying: Common Stock · 233.11 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| May 03, 2019 Filed May 7, 2019 22:52 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 137,840 | $0.00 Strike: $177.31 | $0.00 |
DisclosureSEC source: 0001127602-19-017646 · form4.xml · derivative · entry 3 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,840 Underlying: Common Stock · 137,840 shares Expires 2029-05-03 F4 · derivative.exercise_date: These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/3/2021, 5/3/2022 and 5/3/2023, respectively. Read SEC document |
| May 03, 2019 Filed May 7, 2019 22:52 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 15,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-017646 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 467,392 F2 · security: These shares include the following RSUs granted under the Company's equity plans: 4,784 RSUs which vest on 5/3/2020; 9,890 RSUs which vest in installments of 4,871 on 5/1/2020 and 5,019 on 5/1/2021; 14,087 RSUs which vest in installments of 4,648 on 4/27/2020, 4,649 on 4/27/2021 and 4,790 on 4/27/2022; and 15,791 RSUs which vest in two installments of 5,211 on 5/3/2021 and 5/3/2022 and one installment of 5,369 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/3/2021, 5/3/2022 and 5/3/2023, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 4,784 RSUs which vest on 5/3/2020; 9,890 RSUs which vest in installments of 4,871 on 5/1/2020 and 5,019 on 5/1/2021; 14,087 RSUs which vest in installments of 4,648 on 4/27/2020, 4,649 on 4/27/2021 and 4,790 on 4/27/2022; and 15,791 RSUs which vest in two installments of 5,211 on 5/3/2021 and 5/3/2022 and one installment of 5,369 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 1,383 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 03, 2019 Filed May 7, 2019 22:52 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,379 | $176.50 | $419,893.50 |
DisclosureSEC source: 0001127602-19-017646 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 451,601 F2 · security: These shares include the following RSUs granted under the Company's equity plans: 4,784 RSUs which vest on 5/3/2020; 9,890 RSUs which vest in installments of 4,871 on 5/1/2020 and 5,019 on 5/1/2021; 14,087 RSUs which vest in installments of 4,648 on 4/27/2020, 4,649 on 4/27/2021 and 4,790 on 4/27/2022; and 15,791 RSUs which vest in two installments of 5,211 on 5/3/2021 and 5/3/2022 and one installment of 5,369 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| May 01, 2019 Filed May 3, 2019 21:40 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,433 | $179.32 | $436,293.35 |
DisclosureSEC source: 0001127602-19-017327 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 453,980 F1 · security: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 9,427 RSUs which vest in installments of 4,643 on 5/3/2019 and 4,784 on 5/3/2020; 9,890 RSUs which vest in installments of 4,871 on 5/1/2020 and 5,019 on 5/1/2021; and 14,087 RSUs which vest in installments of 4,648 on 4/27/2020, 4,649 on 4/27/2021 and 4,790 on 4/27/2022. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 9,427 RSUs which vest in installments of 4,643 on 5/3/2019 and 4,784 on 5/3/2020; 9,890 RSUs which vest in installments of 4,871 on 5/1/2020 and 5,019 on 5/1/2021; and 14,087 RSUs which vest in installments of 4,648 on 4/27/2020, 4,649 on 4/27/2021 and 4,790 on 4/27/2022. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 1,776 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:54 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 231.6 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-006349 · doc4.xml · derivative · entry 1 Bradway Robert A · CIK 0001396482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,415.5 Underlying: Common Stock · 231.6 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| March 22, 2019 Filed Mar 25, 2019 23:32 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 25,268 | $191.89 | $4,848,676.52 |
DisclosureSEC source: 0001127602-19-013160 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456,413 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 9,427 RSUs which vest in one equal installment of 4,643 on 5/3/2019 and one installment of 4,784 on 5/3/2020; 14,760 RSUs which vest in installments of 4,870 on 5/1/2019, 4,871 on 5/1/2020 and 5,019 on 5/1/2021; and 14,087 RSUs which vest in installments of 4,648 on 4/27/2020, 4,649 on 4/27/2021 and 4,790 on 4/27/2022. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 2,054 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.